Integer’s Patent Litigation Victory Affirmed on Appeal
Integer Holdings Corporation (NYSE: ITGR) has achieved a significant legal victory as the U.S. Court of Appeals for the Federal Circuit confirmed a judgment of over $27M in its favor against AVX Corporation. This ruling comes after a lengthy patent infringement case initiated in 2013, where Integer's subsidiary, Greatbatch Ltd., accused AVX of infringing three patents related to vital medical device components for pacemakers and defibrillators. Senior VP, Elizabeth Giddens, expressed satisfaction with the outcome, marking it as a complete victory for the company.
- U.S. Court of Appeals affirmed a judgment exceeding $27M in favor of Integer.
- Successful patent infringement case enhances Integer's market position.
- None.
PLANO, Texas, July 15, 2020 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, announced that the United States Court of Appeals for the Federal Circuit affirmed yesterday, in all respects, the judgment in its favor granted in the United States District Court for the District of Delaware in the long-running patent infringement dispute with its competitor, AVX Corporation, and its subsidiary, AVX Filters Corporation.
Integer’s subsidiary, Greatbatch Ltd., was awarded a judgment in an amount exceeding
“We are pleased with this outcome,” said Elizabeth Giddens, Senior Vice President and General Counsel at Integer. “The Federal Circuit’s affirmance was a complete victory for Integer.”
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical, advanced surgical and orthopedics markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical™ and Electrochem® comprise the company’s brands. Additional information is available at www.integer.net.
Investor Relations:
Tony Borowicz
tony.borowicz@integer.net
716.759.5809
Media Relations:
Kelly Butler
kelly.butler@integer.net
214.618.4216
FAQ
What was the recent court ruling regarding Integer Holdings Corporation (ITGR)?
How much was Integer awarded in the patent infringement case?
When was the patent infringement complaint against AVX filed?
What technology was involved in Integer's patent infringement dispute?